Navigation Links
BioMS Medical to present at Rodman and Renshaw Annual Healthcare Conference
Date:11/5/2008

Toronto Stock Exchange Symbol: MS

EDMONTON, Nov. 5 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Kevin Giese, President and CEO, will present at the Rodman and Renshaw 10th Annual Healthcare Conference in New York.

WHEN: Monday November 10th at 12:00pm (Eastern Time)

WHERE: New York Palace Hotel, New York.

About BioMS Medical Corp.

-------------------------

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, dirucotide (MBP8298), is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. In December 2007, BioMS entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to dirucotide (MBP8298), in exchange for an $87 million upfront payment, milestone payments and escalating royalties on sales. For further information please visit our website at http://www.biomsmedical.com.

This press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risks and uncertainties that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changing market conditions, the successful and timely completion of clinical studies, the establishment of corporate alliances, th
'/>"/>

SOURCE BioMS Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
2. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
3. BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
4. BioMS Medical to present at Sachs Associates Biotech in Europe Forum
5. BioMS Medical to present at UBS Global Life Sciences Conference
6. BioMS Medicals lead drug, dirucotide (MBP8298) for the treatment of multiple sclerosis, receives fast track designation from FDA
7. BioMS Medical announces its intention to renew a normal course issuer bid
8. BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
9. BioMS Medical Announces Second Quarter 2008 Results
10. BioMS Medical completes patient recruitment in phase III U.S. multiple sclerosis trial
11. BioMS Medical to present at BMO Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Aug. 21, 2014  Decision Resources Group finds ... and Mexico ... several newly approved agents, the anticipated label extension ... the launch of emerging biologics will substantially increase ... the emerging IL-5 inhibitors will introduce a new dynamic ...
(Date:8/21/2014)... KONG , Aug. 21, 2014  China Cord Blood ... announced its plan to release financial results for the ... 28, 2014, after market close in the US.  ... at 8:00 a.m. ET on Friday, August 29, 2014 ... overview of the Company,s recent developments, followed by a ...
(Date:8/21/2014)... Ontotext S4 , The Self Service ... Now the same enterprise hardened text mining, Linked ... data is available to start-ups and mid-size businesses at ... that do not have resources to evaluate and prototype ... since there is no need for on premise hardware ...
(Date:8/21/2014)... August 21, 2014 On Wednesday of last ... to use Redox Signaling molecules, became available for purchase in ... , "The way that RENU 28 works is, if you ... down of the rate of cellular renewal within your body. ... increasing of that rate of cellular renewal. What RENU 28 ...
Breaking Biology Technology:Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 2Asthma Agents Currently Face a Suboptimal Coverage Environment in Brazil and Mexico, and as the Treatment Armamentarium Expands, Competitiveness Will Further Intensify 3China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 2Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 3Ontotext Releases Text Mining & Semantic Technology Running in the Cloud – Welcome to “S4? 4RENU 28 Skin Care Now Available in Australia and New Zealand 2
... up most of the tab for damage caused by invasive ... other goods imported from countries into the United States every ... financial damage of importing foreign insects into the nation and ... the journal PLoS One today. ,The ...
... Mass High Tech has selected Greenberg Traurig ... its 2011 All-Stars Award, one that recognizes 15 driven ... Camacho will be recognized for her wide ... sciences sector.  As a patent attorney, she represents pharmaceutical ...
... 9, 2011 PharmaVentures Limited, experts ... that they have been engaged by leading drug ... for an established full service CMC (chemistry, manufacturing ... The engagement will utilise PharmaVentures, asset divestment expertise ...
Cached Biology Technology:Homeowners, taxpayers pay billions to fight invasive pests 2Homeowners, taxpayers pay billions to fight invasive pests 3Greenberg Traurig Shareholder Jennifer A. Camacho Selected to Receive Mass High Tech's 2011 All-Stars Award 2
(Date:8/22/2014)... available in German . ... PCFs proteins are fixated in a way so as ... the HZB and Fudan University researchers are planning on ... materials. Their findings are being published today in the ... Proteins are sensitive molecules. Everyone knows that at ...
(Date:8/22/2014)... a multifunctional enzyme that localizes to ... and cholesterol-synthesizing activities. DHCR24 overexpression confers ... β deposition. Dr. Xiuli Lu and ... constructed two recombinant adenoviruses (Ad-rSYN1-DHCR24-myc and ... in neuronal cells. They also found ...
(Date:8/21/2014)... team of scientists including researchers from the University of Georgia ... as canolain the journal Science . Their discovery paves ... used widely in farming and industry. , Canola is ... the winter crop is increasingly cultivated in Georgia. Canola oil ... of saturated fat and rich supply of omega-3 fatty acids, ...
Breaking Biology News(10 mins):Proteins: New class of materials discovered 2Canola genome sequence reveals evolutionary 'love triangle' 2
... "world summit" will bring together internationally renowned scientists from 12 ... India to address ancient microscopic fossils, from July 27 ... together the world,s best scientists in the field of ancient ... of the UCLA Institute of Geophysics and Planetary Physics, Center ...
... A University of Washington study of top-selling laundry products ... different chemicals. All six products tested gave off at ... federal laws, but none of those chemicals was listed ... in this topic because people were telling me that ...
... month remaining before the Beijing Olympics, Chinese officials have introduced ... Games. A new tool has been installed in the capital ... these efforts. Poor air quality could pose problems for ... outdoors in endurance sports, such as cycling and marathons. ...
Cached Biology News:UCLA 'world summit' to explore ancient life on Earth, and beyond 2Toxic chemicals found in common scented laundry products, air fresheners 2Toxic chemicals found in common scented laundry products, air fresheners 3Air quality forecasts for China 2